结构变异检测和对来自16543名阿尔茨海默病测序项目对象的全基因组测序数据的关联分析
Hui Wang1,2, Beth A Dombroski1,2, Po-Liang Cheng1,2
1Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
概括
结构变异 (SVs) 在阿尔茨海默氏症 (AD) 遗传学中起着关键作用. 这项研究发现,阿尔茨海默病患者中单子和同胞性缺失的负担很大,这凸显了SVs在疾病发展中的重要性.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
背景情况:
- 阿尔茨海默病 (AD) 的遗传基础是复杂的,并未完全理解.
- 结构变异 (SVs),大规模的基因组改变,在AD病变发生过程中历史上一直被研究不足.
研究的目的:
- 调查结构变异 (SVs) 在阿尔茨海默氏症 (AD) 中的作用.
- 识别与AD风险相关的特定VS,并了解它们对疾病机制的贡献.
主要方法:
- 分析了阿尔茨海默氏病测序项目的16,543名个体的全基因组测序数据.
- 确定了超过40万个SV,其中的一个子集正在进行实验室验证以确定准确性.
- 进行了统计分析,以确定VS与AD的关联,包括负担分析和链接不平衡 (LD) 研究.
主要成果:
- 在阿尔茨海默病患者中观察到单子和同卵性缺失的显著负担.
- 在已知的AD基因中发现了极为罕见的蛋白质改变性SVs,如ABCA7,APP,PLCG2和SORL1.1.
- 发现几种SV具有高LD,具有已确定的AD风险变体,并且在RNA5SP293附近的新型删除与AD有显著的关联,并在独立队列中复制.
结论:
- 结构变异 (SVs) 是阿尔茨海默病 (AD) 的重要遗传因素.
- 该研究确定了与阿尔茨海默病相关的新型SV和途径,包括影响神经元功能的SV和途径.
- 这些发现强调了在未来的AD遗传研究和治疗策略中考虑SV的重要性.
更多相关视频
相关概念视频
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686


